News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,472 Results
Type
Article (39431)
Company Profile (306)
Press Release (648735)
Section
Business (204786)
Career Advice (2004)
Deals (35475)
Drug Delivery (87)
Drug Development (80993)
Employer Resources (168)
FDA (16116)
Job Trends (14860)
News (345811)
Policy (32547)
Tag
Academia (2548)
Alliances (49432)
Alzheimer's disease (1235)
Approvals (16049)
Artificial intelligence (130)
Bankruptcy (354)
Best Places to Work (11556)
Biotechnology (217)
Breast cancer (121)
Cancer (1087)
Cardiovascular disease (97)
Career advice (1672)
Cell therapy (236)
Clinical research (64368)
Collaboration (390)
Compensation (200)
COVID-19 (2546)
C-suite (95)
Data (1127)
Diabetes (153)
Diagnostics (6160)
Earnings (84949)
Employer resources (146)
Events (109987)
Executive appointments (310)
FDA (16656)
Funding (354)
Gene therapy (178)
GLP-1 (580)
Government (4339)
Healthcare (18689)
Infectious disease (2631)
Inflammatory bowel disease (110)
Interviews (308)
IPO (16330)
Job creations (3659)
Job search strategy (1429)
Layoffs (417)
Legal (7888)
Lung cancer (170)
Manufacturing (177)
Medical device (13185)
Medtech (13190)
Mergers & acquisitions (19218)
Metabolic disorders (403)
Neuroscience (1512)
NextGen Class of 2024 (6534)
Non-profit (4476)
Northern California (1483)
Obesity (231)
Opinion (184)
Patents (102)
People (56595)
Phase I (20012)
Phase II (28363)
Phase III (21127)
Pipeline (458)
Postmarket research (2554)
Preclinical (8525)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5936)
Regulatory (21587)
Research institute (2317)
Resumes & cover letters (350)
Southern California (1307)
Startups (3614)
United States (13523)
Vaccines (550)
Weight loss (168)
Date
Today (133)
Last 7 days (731)
Last 30 days (3759)
Last 365 days (35773)
2024 (32823)
2023 (40177)
2022 (51288)
2021 (55836)
2020 (54158)
2019 (46646)
2018 (35127)
2017 (32223)
2016 (31630)
2015 (37707)
2014 (31454)
2013 (26500)
2012 (28771)
2011 (29426)
2010 (27525)
Location
Africa (716)
Arizona (192)
Asia (37329)
Australia (6106)
California (3344)
Canada (1294)
China (249)
Colorado (147)
Connecticut (152)
Europe (80006)
Florida (460)
Georgia (116)
Illinois (344)
Indiana (197)
Kansas (97)
Maryland (576)
Massachusetts (2617)
Michigan (157)
Minnesota (273)
New Jersey (954)
New York (962)
North Carolina (702)
Northern California (1483)
Ohio (141)
Pennsylvania (846)
South America (1094)
Southern California (1307)
Texas (466)
Utah (90)
Washington State (362)
688,472 Results for "prometheus bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) (NASDAQ: RXDX) acquisition.
June 16, 2023
·
6 min read
Biotech Beach
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
May 9, 2024
·
2 min read
Press Releases
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
November 14, 2024
·
6 min read
Deals
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.
April 16, 2023
·
12 min read
Biotech Beach
Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common Stock
Prometheus Biosciences, Inc. announced that it intends to offer and sell, subject to market and other conditions, $250 million of shares of its common stock in an underwritten public offering.
December 7, 2022
·
4 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
·
6 min read
Press Releases
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
·
4 min read
Biotech Beach
Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common Stock
Prometheus Biosciences, Inc. announced the pricing of an underwritten offering of 4,545,455 shares of its common stock at a price to the public of $110 per share.
December 8, 2022
·
4 min read
Press Releases
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
November 14, 2024
·
8 min read
1 of 68,848
Next
